Antidote Health Seed
Headquarters: New York, New York, United States
Funding Amount: $13M
💸 Last round was raised on August 25, 2021.
Select investors: iAngels, Well-Tech Ventures, Flint Capital
Antidote Health aims to build an AI-based virtual Health maintenance organization (HMO), connecting patients to doctors through a chatbot and video calls. The company offers a model of care inspired by the Israeli healthcare system in which patients pay a monthly membership fee that starts at $29 a month. Antidote also offers a family health plan, where members pay a monthly fee of $59 for unlimited doctor visits, zero copays on most prescription medications — until the patient's 21st doctor visit — and control. There is also the one-time visit option for $49. The company currently operates in New York, New Jersey, Michigan, Florida and North Carolina, with plans to expand to more states, starting with California.
👥 Key people:
- Telehealth use has been growing during the COVID-19 pandemic and now represents a quarter-trillion dollar economic opportunity, according to McKinsey & Company. 🔗
- Antidote's membership business model is good for cashflow.
- This [technology] expertise and ability to simplify processes coupled with Fintech advances that allow for payment from the palm of your hands has made way for Antidote Health's solution to an age-old issue. - Shelly Hod Moyal, iAngels Founding Partner. 🔗
- Antidote's CEO Avihai Soudri previously led the innovation and business development at Leumit and served as CEO of health insurance company Vectis, which was acquired by Swiss-Re in 2019. The company's CTO and Chief Medical Officer are also experienced executives.
Last update: September 6, 2021
Disclaimer: The content on this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances.